Kenta Okada

Twenty-Four-Hour Blood Pressure–Lowering Effect of a Sodium-Glucose Cotransporter 2 Inhibitor in Patients With Diabetes and Uncontrolled Nocturnal Hypertension

Kazuomi Kario, Kenta Okada, Mitsutoshi Kato et al. · Circulation · 2019 · 240 citations

Angiotensin II infusion decreases plasma adiponectin level via its type 1 receptor in rats: an implication for hypertension-related insulin resistance

Jianmin Ran, Tsutomu Hirano, Tomoyasu Fukui et al. · Metabolism · 2006 · 139 citations

Metabolic Syndrome, Hypertension, Type 1 +13

Macrophage lipoprotein lipase modulates the development of atherosclerosis but not adiposity

Manabu Takahashi, Hiroaki Yagyu, Fumiko Tazoe et al. · Journal of Lipid Research · 2013 · 69 citations · Full text

Olmesartan Medoxomil, an Angiotensin II Receptor Blocker Ameliorates Insulin Resistance and Decreases Triglyceride Production in Fructose-Fed Rats

Kenta Okada, Tsutomu Hirano, Jianmin Ran et al. · Hypertension Research · 2004 · 64 citations · Full text

Lipoprotein lipase mRNA in white adipose tissue but not in skeletal muscle is increased by pioglitazone through PPAR-γ

Haruaki Kageyama, Tsutomu Hirano, Kenta Okada et al. · Biochemical and Biophysical Research Communications · 2003 · 58 citations

Metabolic Syndrome, Molecular Physiology, Biochemistry +12